A Digital Exercise Intervention in Patients With Spondyloarthritis
SPARK
The SPARK Trial: a Digital Exercise Intervention in Patients With Spondyloarthritis
1 other identifier
interventional
260
1 country
1
Brief Summary
This protocol describes a 6-month randomised, controlled exercise trial in patients with axial spondyloarthritis (axSpA) with re-randomization after 3-months. The primary outcome of the trial (disease activity) will be evaluated at 3-months. The exercise programme on trial comprises high intensity interval training (HIIT), muscular strength exercise and aerobic physical activity sessions of specified duration, frequency, and intensity. It also includes brief knowledge videos to empower the patient. The intervention is remotely delivered by the SPARK application with personalised follow-up including monitoring to ensure exercise progression and adherence to exercise intensity. The SPARK application is built on a platform delivered by ABEL Technologies (trademark) and is customised for patients with axSpA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2024
CompletedFirst Posted
Study publicly available on registry
June 17, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2030
September 19, 2024
September 1, 2024
3.1 years
May 13, 2024
September 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disease activity 3 months
Number of participants in ASDAS inactive (ASDAS \< 1.3) at 3 months
3 months
Secondary Outcomes (24)
Biologic disease modifying anti-rheumatic drugs 3 months
3 months
Disease activity 6 months
6 months
Proportion of participants using non-steroidal anti-inflammatory drugs
3 and 6 months
Bath ankylosing spondylitis metrology index
3 and 6 months
Bath ankylosing spondylitis function index
3 and 6 months
- +19 more secondary outcomes
Study Arms (4)
Exercise with personal supervision 0-3 months
EXPERIMENTALExercise
Control 0-3 months
NO INTERVENTIONUsual care
Exercise with personal supervision 3-6 months
EXPERIMENTALExercise
Exercise without personal supervision 3-6 months
ACTIVE COMPARATORExercise
Interventions
Remote exercise will be administered with digital supervision. The Exercise group will receive a personalised program with individual adaptations aiming to perform 3 exercise sessions per week including HIIT, strength exercise and moderate intensive aerobic exercise. Participants will consult their rheumatologist parallel to the SPARK trial.
Remote exercise will be administered without digital supervision. Participants will receive a standard exercise program fulfilling the exercise protocol requirements, the exercise program will progress. But there will be no direct contact between the participant and the coach. Participants will consult their rheumatologist parallel to the SPARK trial.
Eligibility Criteria
You may qualify if:
- axSpA diagnosis within the last two years by a rheumatologist according to the ASAS criteria of 2009
- active disease (ASDAS \> 1.3)
You may not qualify if:
- Active uveitis.
- CRP \> 30.
- Former or current use of bDMARDs.
- Absolute and relative contradictions to high intensity exercise according to the American College of Sports Medicine (ACSM)
- Other serious disease such as cancer.
- Patients incapable to follow the protocol or the control set-up with remote monitoring.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diakonhjemmet hospital
Oslo, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The randomization is performed by a study personnel not involved in data collection. Patients are asked not to inform their care-giver or the physiotherapist who perform the study tests which group the patient is allocated to.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2024
First Posted
June 17, 2024
Study Start
July 1, 2024
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2030
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share